Global HERG Screening Market Research Report - Forecast to 2030
상품코드:1368388
리서치사:Market Research Future
발행일:2023년 10월
페이지 정보:영문 107 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 HERG 스크리닝 시장 규모는 예측 기간 중 CAGR로 12.50%의 성장이 예측됩니다.
지역의 인사이트
북미 시장이 2022년에 시장을 선도했습니다(45.80%).
유럽 시장은 2022년에 건전한 시장 점유율을 차지했습니다. 유럽의 서부·동부 지역이 시장의 대부분을 차지하고 있으며, 주요 기여자로 간주되고 있습니다.
아시아태평양 시장은 2023-2032년에 중대한 발전을 보일 전망입니다.
세계의 HERG 스크리닝 시장에 대해 조사분석했으며, 시장 역학, 지역과 부문 분석, 기업 개요 등을 제공하고 있습니다.
목차
제1장 주요 요약
제2장 시장의 서론
제3장 조사 방법
제4장 시장 역학
개요
촉진요인
신약 승인의 증가
심장병의 유병률 증가
억제요인
HERG 스크리닝 제품의 고비용
기회
미개척 시장
COVID-19의 영향
개요
기업에 대한 영향
임상시험에 대한 영향
제5장 시장 요인 분석
공급망 분석
연구개발, 설계
제조
유통
마케팅, 판매
판매 후 모니터링
PORTER'S FIVE FORCES 모델
세계의 HERG 스크리닝 시장의 기술 동향
HERG 서비스 아웃소싱의 증가 동향
패치 클램프 어세이의 등장
시장 기업에 의한 전략적 구상
고객 요구 분석
개요
HERG 스크리닝의 임상시험
원인과 결과 분석
제6장 세계의 HERG 스크리닝 시장 : 유형별
개요
유전자 KCNH2
변이 KCNH2
제7장 세계의 HERG 스크리닝 시장 : 이온채널별
개요
전위 의존성 이온채널
리간드 의존성 이온채널
기타
제8장 세계의 HERG 스크리닝 시장 : 용도별
개요
항부정맥약
항정신병약
항생제
기타
제9장 세계의 HERG 스크리닝 시장 : 지역별
개요
미국
북미
라틴아메리카
유럽
서유럽
동유럽
아시아태평양
중국
일본
인도
호주
한국
기타 아시아태평양
중동 및 아프리카
중동
아프리카
제10장 경쟁 구도
개요
시장 순위 분석
경쟁 벤치마킹
주요 발전과 성장 전략
파트너십
인수
제휴
주요 기업의 재무 매트릭스와 시장 비율
판매, 영업이익률
연구개발비
제11장 기업 개요
THERMO FISHER SCIENTIFIC INC.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
MERCK KGAA
EUROFINS DISCOVERX CORPORATION
ABCAM PLC.
CYPROTEX LIMITED
B'SYS GMBH
CREATIVE BIOARRAY
METRION BIOSCIENCES LTD
AURORA BIOMED INC.
제12장 부록
KSA
영문 목차
영문목차
Market Overview
The HERG Screening Market is anticipated to register a significant CAGR of 12.50% during the forecast period. The rising endorsement of imaginative medications and the ascent in coronary illness commonness are the major market drivers contributing the market development.
As coronary illness is common and the quantity of heart condition patients both ascents, the market is supposed to develop. The market is developing because of expanded Research and development exercises on the side of new item deliveries. Furthermore, it is extended that an ascent in the quantity of creative medication substance endorsements will uphold the market's development. The market is developing as a direct result of both the making of solutions for diseases and problems and the ascent of popularity for drug plans.
Because of the development in examples of cardiotoxicity, there has been a critical interest in screening materials utilized in drug creation. Customary testing techniques may not generally be preferable over HERG tests, yet they might be more secure and more effective when utilized on prescriptions. Cardiovascular medications are progressively having unfavorable aftereffects in patients with prior heart conditions. Cardiotoxicity is more normal in patients who have had malignant growth treatment or cardiovascular medical procedures. Subsequently, there is a rising interest in hardware and administrations that empower productive cardiotoxicity testing. The heart makes some harder memories completing typical capabilities and disseminating blood all through the body when there is cardiotoxicity. Cardiotoxicity thus expands the gamble of cardiomyopathy, which decreases the heart's ability to siphon blood.
Market Segmentation
The HERG Screening market segmentation, based on Type, includes Gene KCNH2 and Mutant KCNH2.
The HERG Screening market segmentation, based on Ion Channel, includes Voltage Gated and Ligand Gated. Based on Application the market is classified into Antiarrhythmic, Antipsychotic, Antibiotics, and Others.
Regional Insights
The North American HERG Screening Market led the market in 2022 (45.80%). At regular intervals, a resident of the US will encounter a myocardial dead tissue, as per the American School of Cardiology. In 2017, 356,460 Americans went through an out-of-clinic heart failure, and in 52% of those cases, crisis clinical benefits were called.
Europe HERG Screening market represented the sound market share in 2022. Europe's western and eastern regions make up most of the market for HERG screening and are both viewed as major contributors.
The Asia Pacific HERG Screening market is supposed to enroll in critical development from 2023 to 2032. A critical part of individuals in space has persistent heart conditions, and the occurrence of fiery problems is rising rapidly too.
Major Players
Major players in the HERG Screening market are Eurofins Scientific, Charles River Laboratories, Merck KGaA, Cyprotex Limited, Creative Bioarray, BSYS GmbH, Aurora Biomed, and Metrion Biosciences.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 14
1.2 MARKET ATTRACTIVENESS ANALYSIS 15
2 MARKET INTRODUCTION
2.1 DEFINITION 16
2.2 SCOPE OF THE STUDY 16
2.3 RESEARCH OBJECTIVE 16
2.4 MARKET STRUCTURE 16
2.5 ASSUMPTIONS & LIMITATIONS 17
3 RESEARCH METHODOLOGY
3.1 DATA MINING 18
3.2 SECONDARY RESEARCH 19
3.3 PRIMARY RESEARCH 20
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21
3.5 FORECASTING TECHNIQUES 21
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.6.1 BOTTOM-UP APPROACH 23
3.6.2 TOP-DOWN APPROACH 23
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 INCREASING NOVEL DRUG APPROVALS 26
4.2.2 INCREASING PREVALENCE OF HEART DISEASES 26
4.3 RESTRAINT 27
4.3.1 HIGH COST OF HERG SCREENING PRODUCTS 27
4.4 OPPORTUNITY 28
4.4.1 UNTAPPED MARKETS 28
4.5 IMPACT OF CORONAVIRUS (COVID)-19 28
4.5.1 OVERVIEW 28
4.5.2 IMPACT ON PLAYERS 28
4.5.3 IMPACT ON CLINICAL TRIALS 28
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 29
5.1.1 R&D AND DESIGNING 29
5.1.2 MANUFACTURING 30
5.1.3 DISTRIBUTION 30
5.1.4 MARKETING & SALES 30
5.1.5 POST-SALES MONITORING 30
5.2 PORTER'S FIVE FORCES MODEL 30
5.2.1 BARGAINING POWER OF SUPPLIERS 31
5.2.2 BARGAINING POWER OF BUYERS 31
5.2.3 THREAT OF NEW ENTRANTS 32
5.2.4 THREAT OF SUBSTITUTES 32
5.2.5 RIVALRY 32
5.3 TECHNOLOGICAL TRENDS IN GLOBAL HERG SCREENING MARKET 32
5.3.1 INCREASING TREND OF OUTSOURCING HERG SERVICES 32
5.3.2 ADVENT OF PATCH CLAMP ASSAY 33
5.3.3 STRATEGIC INITIATIVES BY PLAYERS IN THE MARKET 33
5.4 CUSTOMER NEED ANALYSIS 33
5.4.1 OVERVIEW 33
5.4.2 CLINICAL TRIAL FOR HERG SCREENING 33
5.4.3 CAUSE AND EFFECT ANALYSIS 34
6 GLOBAL HERG SCREENING MARKET, BY TYPE
6.1 OVERVIEW 35
6.2 GENE KCNH2 36
6.3 MUTANT KCNH2 36
7 GLOBAL HERG SCREENING MARKET, BY ION CHANNEL
7.1 OVERVIEW 37
7.2 VOLTAGE-GATED ION CHANNEL 39
7.3 LIGAND-GATED ION CHANNEL 39
7.4 OTHERS 40
8 GLOBAL HERG SCREENING MARKET, BY APPLICATION
8.1 OVERVIEW 41
8.2 ANTIARRHYTHMIC 43
8.3 ANTIPSYCHOTIC 43
8.4 ANTIBIOTIC 43
8.5 OTHERS 44
9 GLOBAL HERG SCREENING MARKET, BY REGION
9.1 OVERVIEW 45
9.2 AMERICAS 47
9.2.1 NORTH AMERICA 49
9.2.1.1 US 51
9.2.1.2 CANADA 52
9.2.2 LATIN AMERICA 53
9.3 EUROPE 54
9.3.1 WESTERN EUROPE 56
9.3.1.1 GERMANY 58
9.3.1.2 FRANCE 59
9.3.1.3 UK 60
9.3.1.4 ITALY 61
9.3.1.5 SPAIN 62
9.3.1.6 REST OF WESTERN EUROPE 63
9.3.2 EASTERN EUROPE 64
9.4 ASIA-PACIFIC 65
9.4.1 CHINA 67
9.4.2 JAPAN 68
9.4.3 INDIA 69
9.4.4 AUSTRALIA 70
9.4.5 SOUTH KOREA 71
9.4.6 REST OF ASIA-PACIFIC 72
9.5 MIDDLE EAST & AFRICA 73
9.5.1 MIDDLE EAST 75
9.5.2 AFRICA 76
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 77
10.2 MARKET RANKING ANALYSIS 77
10.3 COMPETITIVE BENCHMARKING 78
10.4 KEY DEVELOPMENTS AND GROWTH STRATEGIES 79
10.4.1 PARTNERSHIP 79
10.4.2 ACQUISITIONS 80
10.4.3 COLLABORATION 80
10.5 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 81
10.5.1 SALES & OPERATING PROFIT MARGIN 81
10.5.2 R&D EXPENDITURE 81
11 COMPANY PROFILES
11.1 THERMO FISHER SCIENTIFIC INC. 82
11.1.1 COMPANY OVERVIEW 82
11.1.2 FINANCIAL OVERVIEW 82
11.1.3 PRODUCTS/SERVICES OFFERED 83
11.1.4 KEY DEVELOPMENTS 83
11.1.5 SWOT ANALYSIS 83
11.1.6 KEY STRATEGIES 83
11.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 84
